bioAffinity Technologies, Inc. (BIAF)

bioAffinity Technologies will go public soon, but the exact IPO date is still unknown.
Stock Price: $6.75
Confirmed IPO price

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20202021
Selling, General & Admin
0.990.88
Research & Development
1.611.33
Operating Expenses
2.62.21
Operating Income
-2.6-2.21
Interest Expense / Income
0.381
Other Expense / Income
4.283.12
Pretax Income
-7.27-6.32
Income Tax
00
Net Income
-7.27-6.33
Net Income Common
-7.27-6.33
Effective Tax Rate
-0.04%-0.03%
EBITDA
-6.86-5.32
Depreciation & Amortization
0.020
EBIT
-6.88-5.32
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).